Turim 21 Investimentos’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Turim 21 Investimentos’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8K	Hold	109	–	–	﹤0.01%	95
2026 Q1	$9.45K	Buy	+109	New	+$9.54K	﹤0.01%	92

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Turim 21 Investimentos's IHE Position: Q2 2026 in Review

Turim 21 Investimentos held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 109 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #95.

Turim 21 Investimentos first reported a position in IHE in Q1 2026 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Turim 21 Investimentos held 109 shares of iShares US Pharmaceuticals ETF worth $10.8K as of Q2 2026.
Turim 21 Investimentos left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Turim 21 Investimentos's portfolio in Q2 2026, its #95 holding.
Turim 21 Investimentos first reported a position in iShares US Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Turim 21 Investimentos's 13F filing for Q2 2026, filed 10 Aug 2026.